Grayson and Holtzman (2007). Dendritic cells in the Lung. - Emerging Role of Dendritic Cells in Respiratory Viral Infections

Respiratory viral infections, such as those caused by respiratory syncytial virus (RSV) and influenza virus, pose significant health risks, especially for vulnerable populations including the immunocompromised, infants, and the elderly. The successful clearance of these viral infections is heavily reliant on an effective adaptive immune response, which is primarily initiated and coordinated by dendritic cells (DCs). These specialized antigen-presenting cells play a pivotal role in activating T lymphocytes during the crucial early stages of an antiviral response.

Types of Dendritic Cells
Conventional Dendritic Cells (cDCs)

Conventional dendritic cells are categorized into different subtypes based on distinct surface markers, such as CD11c and MHC class II. They are primarily recognized for their role in antigen presentation and are vital for linking innate and adaptive immunity. cDCs develop in the bone marrow and migrate to peripheral tissues in an immature state. Upon encountering foreign antigens and recognizing danger signals, they mature and migrate to lymph nodes, where they express elevated levels of costimulatory molecules (like CD80 and CD86) and MHC molecules, thereby facilitating the activation of T cells. cDCs are capable of persisting in tissues for limited durations, forming dynamic networks that engage with both T cells and other immune components to orchestrate effective adaptive immune responses.

Plasmacytoid Dendritic Cells (pDCs)

In contrast to cDCs, plasmacytoid dendritic cells are characterized by their relatively lower efficiency in antigen presentation; however, they are indispensable for antiviral responses due to their high capacity for type I interferon production, particularly IFN-α. These cells modulate the T cell landscape by creating a cytokine environment that skews responses towards specific immune pathways, such as promoting Th1 responses. Recent studies suggest that pDCs can also have regulatory roles, suppressing T cell proliferation and influencing the balance between Th1 and Th2 immune responses through the release of various cytokines and chemokines.

Interferon-Producing Killer Dendritic Cells (IKDC)

A newer subset known as interferon-producing killer dendritic cells exhibit unique characteristics that blend features of both DCs and natural killer (NK) cells. IKDCs express a combination of markers from both cell types and possess abilities to produce substantial amounts of interferon-α and interleukin-12 (IL-12), alongside exhibiting cytotoxic capabilities typical of NK cells. The precise roles and signaling pathways employed by IKDCs in developing antiviral defense mechanisms remain an area of active research, revealing complex interactions within the immune system.

Function and Life Cycle of Dendritic Cells in the Lung

Lung dendritic cells are strategically positioned within the respiratory tract to monitor and respond proactively to inhaled pathogens. Upon encountering airborne antigens, cDCs uptake these substances and undergo a maturation process that enhances their antigen-presenting capabilities. They extend dendritic processes into the airway lumen, facilitating optimal interaction with inhaled pathogens. The maturation of cDCs leads to a reorganization of chemokine receptors, directing their migration to lymph nodes where they effectively engage with T cells, initiating the adaptive immune response.

While pDCs are present in fewer numbers within the lung environment, they demonstrate a rapid proliferation in response to viral infections, often becoming predominant as the infection progresses. In addition to migration to draining lymph nodes, pDCs are adept at producing critical cytokines such as IFN-α, ultimately directing the skewing of T cell responses and enhancing the overall antiviral response.

Dendritic Cells and Viral Infections

Dendritic cells utilize various mechanisms to acquire and present viral antigens effectively. These mechanisms can include:

  • Direct Infection: Some viruses directly infect DCs, allowing for the intracellular presentation of viral antigens.

  • Autophagy: Internalization of cellular debris containing viral components can aid in antigen processing.

  • Ingestion of Apoptotic Cells: DCs can engulf apoptotic cells from infected tissues, obtaining viral antigens for presentation.

  • Cross-Presentation: A unique ability of cDCs to present extracellularly derived viral peptides via MHC class I molecules, which is crucial for stimulating CD8+ T cell responses that are essential for controlling virally infected cells.

Type I Interferons in Viral Response

Dendritic cells play a fundamental role in producing type I interferons (IFN-α/β), which are critical for orchestrating antiviral immune responses. The synthesis of these interferons occurs through distinct signaling pathways in cDCs and pDCs: pDCs primarily trigger IFN-α production upon engagement of Toll-like receptors (TLRs), particularly TLR-7, recognizing viral RNA. Type I interferons function across various immune cell types, enhancing their antiviral capacities and establishing robust adaptive immunity.

Evasion Strategies of Respiratory Viruses

Respiratory viruses have evolved sophisticated mechanisms to evade dendritic cell-mediated immune responses. Some examples include:

  • Herpes Simplex Virus (HSV): This virus can inhibit CCR7 expression, thereby preventing optimal DC migration toward lymph nodes, which is necessary for effective T cell activation.

  • Human Immunodeficiency Virus (HIV): HIV employs various proteins that downregulate MHC class I expression on infected cells, which hampers reliable antigen presentation needed for robust T cell responses.

Understanding the diverse evasion strategies employed by respiratory viruses is paramount for developing effective therapeutic approaches that can enhance immune detection and response against viral infections.

Case Studies: RSV and Influenza
Respiratory Syncytial Virus (RSV)

RSV is a leading cause of respiratory illness in infants. Notably, RSV not only replicates within conventional dendritic cells but can also significantly alter their functionality. Studies have shown that RSV can suppress dendritic cell maturation, which ultimately hampers the immune system's ability to mount a full-fledged response against the infection both locally in the lung and systemically.

Influenza Virus

The influenza virus presents unique challenges to the host due to its multifaceted effects on dendritic cell functions. For example, the NS1 protein produced by influenza may inhibit dendritic cell maturation and function, leading to insufficient activation of T cells. However, interventions utilizing IFN-α have displayed potential in reversing some suppressive effects of viral proteins on dendritic cells, opening doors for earlier therapeutic strategies against influenza.

Conclusion

Through extensive research, it is evident that dendritic cells are not merely passive elements in the immune system but rather critical orchestrators of the immune response against respiratory viral infections. Future research should focus on understanding the nuanced mechanisms governing dendritic cell function and the innovative therapeutic strategies aimed at enhancing these functions or counteracting the evasion tactics employed by respiratory viruses. Optimizing interventions leveraging dendritic cell-targeted therapies holds substantial promise in improving outcomes for patients suffering from viral respiratory diseases.